Pr LEPAGE Côme

Fiche personne


coordonnées

Hôpital Mitterrand
14 rue Gaffarel
BP 77908
21079 DIJON Cedex

03 80 29 37 50

come.lepage@u-bourgogne.fr

Territoire

Bourgogne

Statut

Hospitalo-Universitaire

Recherche

Expertises :
- Recherche:Epidémiologie
- Clinique:Hépato-Gastro-Entérologie
- Cancer:Colorectal
- Plate-forme:Epidémiologie

Projets


Voir plus

Publications


Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours: An international double-blind, placebo-controlled randomised phase II trial - Prodige 31 REMINET: An FFCD study.

Lepage C, Phelip JM, Lievre A, Le-Malicot K, Dahan L, Tougeron D, Toumpanakis C, Di-Fiore F, Lombard-Bohas C, Borbath I, Coriat R, Lecomte T, Guimbaud R, Petorin C, Legoux JL, Michel P, Scoazec JY, Smith D, Walter T

Eur J Cancer. 2022 09 7;175:31-40

Efficacy of donepezil for the treatment of oxaliplatin-induced peripheral neuropathy: DONEPEZOX, a protocol of a proof of concept, randomised, triple-blinded and multicentre trial.

Kerckhove N, Tougeron D, Lepage C, Pezet D, Le Malicot K, Pelkowski M, Pereira B, Balayssac D

BMC Cancer. 2022 07 7;22(1):742

Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer.

Derangère V, Lecuelle J, Lepage C, Aoulad-Ben Salem O, Allatessem BM, Ilie A, Bouché O, Phelip JM, Baconnier M, Pezet D, Sebbagh V, Terrebonne E, Bouard G, Jooste V, Bouvier AM, Molimard C, Monnien F, Gonzalez D, Le Malicot K, Rageot D, Truntzer C, Bibeau F, Ghiringhelli F,

Eur J Cancer. 2022 07 1;172:221-230

Voir plus